Dow (DOW)
(Delayed Data from NYSE)
$52.76 USD
0.00 (0.00%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $52.76 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth C Momentum C VGM
We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies, revised Privacy Policy and Terms of Service.
You are being directed to ZacksTrade, a division of LBMZ Securities and licensed broker-dealer. ZacksTrade and Zacks.com are separate companies. The web link between the two companies is not a solicitation or offer to invest in a particular security or type of security. ZacksTrade does not endorse or adopt any particular investment strategy, any analyst opinion/rating/report or any approach to evaluating individual securities.
If you wish to go to ZacksTrade, click OK. If you do not, click Cancel.
$52.76 USD
0.00 (0.00%)
Updated Aug 14, 2024 04:00 PM ET
After-Market: $52.76 0.00 (0.00%) 7:58 PM ET
5-Strong Sell of 5 5
C Value C Growth C Momentum C VGM
Zacks News
ETFs to Watch on Likely Q3 Earnings Surprise for Materials
by Sweta Killa
With positive earnings estimate revision and earnings surprises in the cards, materials ETFs might continue to see smooth trading in the weeks ahead.
5 Chemical Stocks Likely to Outshine Q3 Earnings Estimates
by Anindya Barman
Improved end-market demand and benefits of self-help actions are likely to reflect on the Q3 performance of Axalta Coating (AXTA), Rayonier (RYAM), Dow (DOW), DuPont (DD) and Eastman (EMN).
Is a Surprise Coming for Dow (DOW) This Earnings Season?
by Zacks Equity Research
Dow (DOW) is seeing favorable earnings estimate revision activity and has a positive Zacks Earnings ESP heading into earnings season.
Dow (DOW) Warms Up to Q3 Earnings: What's in the Offing?
by Zacks Equity Research
Dow (DOW) is likely to have benefited from its expense-control actions in the third quarter.
Dow Inc. (DOW) Expected to Beat Earnings Estimates: What to Know Ahead of Q3 Release
by Zacks Equity Research
Dow Inc. (DOW) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
HUN vs. DOW: Which Stock Should Value Investors Buy Now?
by Zacks Equity Research
HUN vs. DOW: Which Stock Is the Better Value Option?
Avient (AVNT) Catches Eye: Stock Jumps 7.2%
by Zacks Equity Research
Avient (AVNT) saw a big move last session, as its shares jumped more than 7% on the day, amid huge volumes.
6 Must-Buy Stocks on the Dip for a Likely Volatile October
by Nalak Das
At this stage, it will be prudent to invest in stocks with a Zacks Rank #1 (Strong Buy) that are also trading at a huge discount to their 52-week high prices.
Dow Announces Restructuring Actions to Boost Cost Savings
by Zacks Equity Research
Dow (DOW) expects these restructuring actions to result in total annualized EBITDA savings of more than $300 million by the end of 2021.
Dow (DOW) Stock Up 59% in 6 Months: What's Behind the Rally?
by Zacks Equity Research
Dow (DOW) gains on cost synergy savings and productivity initiatives and its investment in high-return projects.
Global Chemical Output Growth Speeds Up as Activities Recover
by Anindya Barman
Global chemical production growth accelerates in August on gains across all regions and industry segments.
Dow's Collaboration With Luhai to Boost Plastics Circularity
by Zacks Equity Research
This strategic partnership will enable Dow (DOW) to develop new circular plastic solutions for the Asia Pacific market.
The Zacks Analyst Blog Highlights: Dow, Salesforce, Apple, Walmart and UnitedHealth
by Zacks Equity Research
The Zacks Analyst Blog Highlights: Dow, Salesforce, Apple, Walmart and UnitedHealth
Top 6 Dow Stocks to Boost Portfolio in a Capricious Market
by Nalak Das
Despite an unpredictable market, six Dow stocks with a favorable Zacks Rank are likely to provide solid returns in the near term.
US Chemical August Output Nudges Up on Manufacturing Strength
by Anindya Barman
U.S. chemical production expanded 0.6% in August as recovery gained steam in the manufacturing sector.
First Solar to Supply Series 6 Modules to France Solar Plant
by Zacks Equity Research
With over 1,100MWs installed, First Solar's (FSLR) advanced module thin film technology forms the backbone of France's solar fleet.
What Makes Dow (DOW) a Solid Investment Option Right Now
by Zacks Equity Research
Dow (DOW) benefits from cost and productivity actions and its investment in high-return growth projects.
Dow (DOW) to Divest U.S. Gulf Coast Assets for $620 Million
by Zacks Equity Research
Dow (DOW) is assessing its ownership of non-revenue-generating assets across its global portfolio. The deal will enable the company deploy cash toward value-enhancing opportunities in core businesses.
Dow Jones Tops 29,000: Will ETFs & Stocks Rally in September?
by Sanghamitra Saha
The Dow jumped above 29,000 for the first time since February on Sep 2 on low rates and vaccine hopes.
Dow (DOW) Polyurethanes Accelerates Digital Transformation
by Zacks Equity Research
The move will transform Dow's (DOW) product development process and improve customer collaboration.
Dow (DOW) Completes Senior Notes Offering Worth $2 Billion
by Zacks Equity Research
Dow's (DOW) fully-owned subsidiary will employ the net proceeds to fund the redemption of debt.
Dow Inc. (DOW) Up 1.8% Since Last Earnings Report: Can It Continue?
by Zacks Equity Research
Dow Inc. (DOW) reported earnings 30 days ago. What's next for the stock? We take a look at earnings estimates for some clues.
Coronavirus Clouds Diversified Chemical Industry Outlook
by Anindya Barman
Diversified chemicals companies are buffeted by a downturn in demand across major markets and raw material cost pressure due to coronavirus.
Material ETFs Well Poised for Gains As Q2 Earnings Unfold
by Sweta Killa
The materials sector has shown remarkable performance after the reopening of the economy as industrials and business activities have picked up.
Dow's (DOW) Earnings and Revenues Beat Estimates in Q2
by Zacks Equity Research
Lower local pricing and a decline in volumes due to the coronavirus pandemic hurt Dow's (DOW) revenues in Q2.